Is Trigyn Techno. overvalued or undervalued?

As of 17 October 2025, Trigyn Technologies has moved from an expensive to a fair valuation grade. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of -2570.38, an EV to EBITDA of -25.25, and a Price to Book Value of 0.32, indicating significant challenges in profitability and capital efficiency.
In comparison to its peers, Trigyn's valuation metrics stand out, particularly against TCS with a PE of 21.31 and Infosys at 21.29, both of which are considered attractive and fair, respectively. The substantial negative PE ratio of Trigyn highlights its struggles relative to the industry, where companies like HCL Technologies and Wipro are performing better with PE ratios of 23.78 and 18.7, respectively. Notably, Trigyn's stock has underperformed against the Sensex, with a year-to-date return of -28.40% compared to the Sensex's 7.44%, reinforcing its current valuation status.